Niacin randomized controlled trial wax-matrix sustained-release niacin hypercholesterolemia male female subjects years low-density lipoprotein cholesterol values percentiles randomized double-blind study new form niacin Enduracin wax-matrix vehicle sustained release niacin treatment groups daily doses mg placebo- diet-treated controls side-effect profile optimal range efficacy groups mg significant reductions values low-density lipoprotein cholesterol total cholesterol total cholesterol-high-density lipoprotein cholesterol ratio diet- placebo-treated controls Smaller improvements high-density lipoprotein cholesterol triglyceride levels Blood chemistry monitoring reduction low-density lipoprotein cholesterol level increase baseline levels enzymes niacin-treated subjects improved side-effect profile wax-matrix form niacin notable dropout rate due effects good medication compliance 